Sign In
Buy HRMY
$35.24
-0.620 (-1.73%)
At Close: Jul 31, 2026
Harmony Biosciences Holdings, Inc. 2021 Q3 - Results - Earnings Call Presentation
11:38am, Sunday, 14'th Nov 2021 Seeking AlphaHarmony Biosciences Holdings, Inc. (HRMY) CEO John Jacobs on Q3 2021 Results - Earnings Call Transcript
05:37am, Sunday, 14'th Nov 2021
Harmony Biosciences Holdings, Inc. (HRMY) CEO John Jacobs on Q3 2021 Results - Earnings Call Transcript
Harmony Biosciences To Participate In Two Investor Conferences In November
08:05am, Thursday, 11'th Nov 2021
PLYMOUTH MEETING, Pa., Nov. 11, 2021 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative t
Harmony Biosciences Holdings, Inc. (HRMY) Tops Q3 Earnings and Revenue Estimates
10:43am, Tuesday, 09'th Nov 2021
Harmony Biosciences Holdings, Inc. (HRMY) delivered earnings and revenue surprises of 88.89% and 1.81%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead
Our First Look At Harmony Biosciences
05:16pm, Thursday, 04'th Nov 2021
Today, we take our first in-depth look at Harmony Biosciences who IPO'd late in 2020. The company's primary compound WAKIX is seeing impressive sales growth and Harmony is already profitable.
Harmony Biosciences Announces Date of Third Quarter 2021 Financial Results
08:05am, Tuesday, 26'th Oct 2021
PLYMOUTH MEETING, Pa., Oct. 26, 2021 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializi
Harmony Biosciences Holdings, Inc. (HRMY) Surges 10.2%: Is This an Indication of Further Gains?
10:10am, Wednesday, 20'th Oct 2021
Harmony Biosciences Holdings, Inc. (HRMY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving h
5 Stocks for Higher Returns as Analysts Initiate Coverage
10:50am, Tuesday, 28'th Sep 2021
Increased analyst coverage over the past few weeks might lead to solid price appreciation for stocks like Alpha and Omega (AOSL), Preferred Apartment (APTS), Hut 8 Mining (HUT), GCM (GCMG) & Harmony B
Harmony Biosciences Announces Winners of Patients at the Heart and Progress at the Heart on Third Annual World Narcolepsy Day
08:05am, Wednesday, 22'nd Sep 2021
PLYMOUTH MEETING, Pa., Sept. 22, 2021 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative t
Harmony Biosciences To Participate In Three Investor Conferences In September
08:05am, Thursday, 02'nd Sep 2021
PLYMOUTH MEETING, Pa., Sept. 2, 2021 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative the
Harmony Biosciences Stock Is Trading Higher On $330M Financing Deal With Blackstone, Q2 Earning Beat Estimates
03:52pm, Tuesday, 10'th Aug 2021
Harmony Biosciences Holdings Inc (NASDAQ: HRMY) has entered into a $330 million financing collaboration with The Blackstone Group Inc (NYSE: BX). The financing deal includes up to $300 million in
Harmony Biosciences Holdings, Inc. (HRMY) CEO John Jacobs on Q2 2021 Results - Earnings Call Transcript
02:47pm, Tuesday, 10'th Aug 2021
Harmony Biosciences Holdings, Inc. (HRMY) CEO John Jacobs on Q2 2021 Results - Earnings Call Transcript
HRMY Stock Price Increases Over 20% Intraday: Why It Happened
01:49pm, Tuesday, 10'th Aug 2021
The stock price of Harmony Biosciences Holdings Inc (NASDAQ: HRMY) increased by over 20% during intraday trading. This is why it happened.
Harmony Biosciences Reports Second Quarter 2021 Financial Results and Business Updates
08:00am, Tuesday, 10'th Aug 2021
WAKIX® (pitolisant) Net Revenue of $73.8 Million for Second Quarter 2021 vs. $38 Million for the Same Period in 2020
PLYMOUTH MEETING, Pa., Aug. 9, 2021 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative
